Regulation of Human CD27+IgM+B Cell Activation by Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L)

被引:1
|
作者
Dijke, Esme [1 ,2 ]
Derkatz, Kim [1 ,2 ]
Pearcey, Jean [1 ,2 ]
Wong, Fred [1 ,2 ]
Motyka, Bruce [1 ,2 ]
West, Lori [1 ,2 ]
机构
[1] Univ Alberta, Pediat, Edmonton, AB, Canada
[2] Univ Alberta, Alberta Transplant Inst, Edmonton, AB, Canada
关键词
D O I
10.1097/01.tp.0000520297.36145.fc
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
115.5
引用
收藏
页码:S5 / S5
页数:1
相关论文
共 50 条
  • [41] The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
    Kelm, S
    Gerlach, J
    Brossmer, R
    Danzer, CP
    Nitschke, L
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09): : 1207 - 1213
  • [42] Analysis of tyrosine phosphorylation sites of CD22 upon B cell activation
    Fujimoto, M
    Yoshitake, S
    Tedder, TF
    Takehara, K
    FASEB JOURNAL, 2005, 19 (04): : A953 - A953
  • [43] CD22 deficiency influences the incidence of B cell lymphoma
    Inaoki, M
    Sato, S
    Hasegawa, M
    Tedder, TF
    Takehara, K
    FASEB JOURNAL, 2003, 17 (07): : C324 - C324
  • [44] Insights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia
    Enkhbayar, Bayarmaa
    Lu, Shao-Chia
    Tsai, Ho-Yang
    Liang, Suh-Yuen
    Wu, Shang-Ju
    Lin, Kuo-, I
    Angata, Takashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (04)
  • [45] Role in B cell activation for CD22 and the protein tyrosine phosphatase SHP
    Doody, G.M.
    Justement, L.B.
    Delibrias, C.C.
    Matthews, R.J.
    Lin, J.
    Thomas, M.L.
    Fearon, D.T.
    Science, 1995, 269 (5221)
  • [46] Abnormal levels of the α chain of the CD22 adhesion molecule may account for low CD22 surface expression in chronic lymphocytic leukemia
    B Payelle-Brogard
    G Dumas
    C Magnac
    A I Lalanne
    G Dighiero
    F Vuillier
    Leukemia, 2006, 20 : 877 - 878
  • [47] Comparison of CD22 binding to native CD45 and synthetic oligosaccharide
    Bakker, TR
    Piperi, C
    Davies, EA
    van der Merwe, PA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (07) : 1924 - 1932
  • [48] DEVELOPMENT OF HUMAN B-CELL LINES DEFICIENT IN CD19, CD20, OR CD22
    WILSON, GL
    RIVA, A
    KEHRL, JH
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A99 - A99
  • [49] Role of CD22/Siglec-2 and its ligand in B lymphocyte activation
    Matsubara, Naoko
    Takematsu, Hiromu
    Ishida, Hideharu
    Tsubata, Takeshi
    GLYCOBIOLOGY, 2014, 24 (11) : 1090 - 1090
  • [50] Phosphorous carbohydrates on chimeric CD22, CD44 and CD62L
    Jonsson, G
    Gelius, E
    BraeschAndersen, S
    IMMUNOLOGY LETTERS, 1996, 52 (01) : 31 - 35